Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 14 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis
This report studies the global Recombinant Insulin Lispro Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Insulin Lispro Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Insulin Lispro Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Insulin Lispro Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Insulin Lispro Injection total production value, 2018-2029, (USD Million)
Global Recombinant Insulin Lispro Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Insulin Lispro Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Insulin Lispro Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Insulin Lispro Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GT, Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Novo Nordisk, Pfizer, BI, Sanofi, Takeda Pharmaceutical Company and Wanbang Biopharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Insulin Lispro Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Insulin Lispro Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Insulin Lispro Injection Market, Segmentation by Type
    1ML
    3ML
    10ML

Global Recombinant Insulin Lispro Injection Market, Segmentation by Application
    Hospital
    Pharmacy

Companies Profiled:
    GT
    Tonghua Dongbao Pharmaceutical
    Eli Lilly and Company
    Novo Nordisk
    Pfizer
    BI
    Sanofi
    Takeda Pharmaceutical Company
    Wanbang Biopharmaceuticals
    United Laboratories

Key Questions Answered
1. How big is the global Recombinant Insulin Lispro Injection market?
2. What is the demand of the global Recombinant Insulin Lispro Injection market?
3. What is the year over year growth of the global Recombinant Insulin Lispro Injection market?
4. What is the production and production value of the global Recombinant Insulin Lispro Injection market?
5. Who are the key producers in the global Recombinant Insulin Lispro Injection market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Insulin Lispro Injection Introduction
    1.2 World Recombinant Insulin Lispro Injection Supply & Forecast
        1.2.1 World Recombinant Insulin Lispro Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Insulin Lispro Injection Production (2018-2029)
        1.2.3 World Recombinant Insulin Lispro Injection Pricing Trends (2018-2029)
    1.3 World Recombinant Insulin Lispro Injection Production by Region (Based on Production Site)
        1.3.1 World Recombinant Insulin Lispro Injection Production Value by Region (2018-2029)
        1.3.2 World Recombinant Insulin Lispro Injection Production by Region (2018-2029)
        1.3.3 World Recombinant Insulin Lispro Injection Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Insulin Lispro Injection Production (2018-2029)
        1.3.5 Europe Recombinant Insulin Lispro Injection Production (2018-2029)
        1.3.6 China Recombinant Insulin Lispro Injection Production (2018-2029)
        1.3.7 Japan Recombinant Insulin Lispro Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Insulin Lispro Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Insulin Lispro Injection Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Insulin Lispro Injection Demand (2018-2029)
    2.2 World Recombinant Insulin Lispro Injection Consumption by Region
        2.2.1 World Recombinant Insulin Lispro Injection Consumption by Region (2018-2023)
        2.2.2 World Recombinant Insulin Lispro Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.4 China Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.5 Europe Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.6 Japan Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.7 South Korea Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.8 ASEAN Recombinant Insulin Lispro Injection Consumption (2018-2029)
    2.9 India Recombinant Insulin Lispro Injection Consumption (2018-2029)

3 World Recombinant Insulin Lispro Injection Manufacturers Competitive Analysis
    3.1 World Recombinant Insulin Lispro Injection Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Insulin Lispro Injection Production by Manufacturer (2018-2023)
    3.3 World Recombinant Insulin Lispro Injection Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Insulin Lispro Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Insulin Lispro Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Insulin Lispro Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Insulin Lispro Injection in 2022
    3.6 Recombinant Insulin Lispro Injection Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Insulin Lispro Injection Market: Region Footprint
        3.6.2 Recombinant Insulin Lispro Injection Market: Company Product Type Footprint
        3.6.3 Recombinant Insulin Lispro Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Insulin Lispro Injection Production Value Comparison
        4.1.1 United States VS China: Recombinant Insulin Lispro Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Insulin Lispro Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Insulin Lispro Injection Production Comparison
        4.2.1 United States VS China: Recombinant Insulin Lispro Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Insulin Lispro Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Insulin Lispro Injection Consumption Comparison
        4.3.1 United States VS China: Recombinant Insulin Lispro Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Insulin Lispro Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Insulin Lispro Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023)
    4.5 China Based Recombinant Insulin Lispro Injection Manufacturers and Market Share
        4.5.1 China Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023)
    4.6 Rest of World Based Recombinant Insulin Lispro Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Insulin Lispro Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 1ML
        5.2.2 3ML
        5.2.3 10ML
    5.3 Market Segment by Type
        5.3.1 World Recombinant Insulin Lispro Injection Production by Type (2018-2029)
        5.3.2 World Recombinant Insulin Lispro Injection Production Value by Type (2018-2029)
        5.3.3 World Recombinant Insulin Lispro Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Insulin Lispro Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Recombinant Insulin Lispro Injection Production by Application (2018-2029)
        6.3.2 World Recombinant Insulin Lispro Injection Production Value by Application (2018-2029)
        6.3.3 World Recombinant Insulin Lispro Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 GT
        7.1.1 GT Details
        7.1.2 GT Major Business
        7.1.3 GT Recombinant Insulin Lispro Injection Product and Services
        7.1.4 GT Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 GT Recent Developments/Updates
        7.1.6 GT Competitive Strengths & Weaknesses
    7.2 Tonghua Dongbao Pharmaceutical
        7.2.1 Tonghua Dongbao Pharmaceutical Details
        7.2.2 Tonghua Dongbao Pharmaceutical Major Business
        7.2.3 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product and Services
        7.2.4 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
        7.2.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
    7.3 Eli Lilly and Company
        7.3.1 Eli Lilly and Company Details
        7.3.2 Eli Lilly and Company Major Business
        7.3.3 Eli Lilly and Company Recombinant Insulin Lispro Injection Product and Services
        7.3.4 Eli Lilly and Company Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Eli Lilly and Company Recent Developments/Updates
        7.3.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.4 Novo Nordisk
        7.4.1 Novo Nordisk Details
        7.4.2 Novo Nordisk Major Business
        7.4.3 Novo Nordisk Recombinant Insulin Lispro Injection Product and Services
        7.4.4 Novo Nordisk Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Novo Nordisk Recent Developments/Updates
        7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Recombinant Insulin Lispro Injection Product and Services
        7.5.4 Pfizer Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 BI
        7.6.1 BI Details
        7.6.2 BI Major Business
        7.6.3 BI Recombinant Insulin Lispro Injection Product and Services
        7.6.4 BI Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 BI Recent Developments/Updates
        7.6.6 BI Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Recombinant Insulin Lispro Injection Product and Services
        7.7.4 Sanofi Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 Takeda Pharmaceutical Company
        7.8.1 Takeda Pharmaceutical Company Details
        7.8.2 Takeda Pharmaceutical Company Major Business
        7.8.3 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product and Services
        7.8.4 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
        7.8.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
    7.9 Wanbang Biopharmaceuticals
        7.9.1 Wanbang Biopharmaceuticals Details
        7.9.2 Wanbang Biopharmaceuticals Major Business
        7.9.3 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product and Services
        7.9.4 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
        7.9.6 Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
    7.10 United Laboratories
        7.10.1 United Laboratories Details
        7.10.2 United Laboratories Major Business
        7.10.3 United Laboratories Recombinant Insulin Lispro Injection Product and Services
        7.10.4 United Laboratories Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 United Laboratories Recent Developments/Updates
        7.10.6 United Laboratories Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Insulin Lispro Injection Industry Chain
    8.2 Recombinant Insulin Lispro Injection Upstream Analysis
        8.2.1 Recombinant Insulin Lispro Injection Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Insulin Lispro Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Insulin Lispro Injection Production Mode
    8.6 Recombinant Insulin Lispro Injection Procurement Model
    8.7 Recombinant Insulin Lispro Injection Industry Sales Model and Sales Channels
        8.7.1 Recombinant Insulin Lispro Injection Sales Model
        8.7.2 Recombinant Insulin Lispro Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Insulin Lispro Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Insulin Lispro Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Insulin Lispro Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Insulin Lispro Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Recombinant Insulin Lispro Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Recombinant Insulin Lispro Injection Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Insulin Lispro Injection Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Insulin Lispro Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Recombinant Insulin Lispro Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Recombinant Insulin Lispro Injection Major Market Trends
    Table 13. World Recombinant Insulin Lispro Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Recombinant Insulin Lispro Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Recombinant Insulin Lispro Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Recombinant Insulin Lispro Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Insulin Lispro Injection Producers in 2022
    Table 18. World Recombinant Insulin Lispro Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Recombinant Insulin Lispro Injection Producers in 2022
    Table 20. World Recombinant Insulin Lispro Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Recombinant Insulin Lispro Injection Company Evaluation Quadrant
    Table 22. World Recombinant Insulin Lispro Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Insulin Lispro Injection Production Site of Key Manufacturer
    Table 24. Recombinant Insulin Lispro Injection Market: Company Product Type Footprint
    Table 25. Recombinant Insulin Lispro Injection Market: Company Product Application Footprint
    Table 26. Recombinant Insulin Lispro Injection Competitive Factors
    Table 27. Recombinant Insulin Lispro Injection New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Insulin Lispro Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Insulin Lispro Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Insulin Lispro Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Recombinant Insulin Lispro Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2018-2023)
    Table 37. China Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2018-2023)
    Table 47. World Recombinant Insulin Lispro Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Insulin Lispro Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Recombinant Insulin Lispro Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Recombinant Insulin Lispro Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Insulin Lispro Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Insulin Lispro Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Recombinant Insulin Lispro Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Recombinant Insulin Lispro Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Insulin Lispro Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Recombinant Insulin Lispro Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Recombinant Insulin Lispro Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Insulin Lispro Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Insulin Lispro Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Recombinant Insulin Lispro Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. GT Basic Information, Manufacturing Base and Competitors
    Table 62. GT Major Business
    Table 63. GT Recombinant Insulin Lispro Injection Product and Services
    Table 64. GT Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. GT Recent Developments/Updates
    Table 66. GT Competitive Strengths & Weaknesses
    Table 67. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 68. Tonghua Dongbao Pharmaceutical Major Business
    Table 69. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product and Services
    Table 70. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
    Table 72. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
    Table 73. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 74. Eli Lilly and Company Major Business
    Table 75. Eli Lilly and Company Recombinant Insulin Lispro Injection Product and Services
    Table 76. Eli Lilly and Company Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Eli Lilly and Company Recent Developments/Updates
    Table 78. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 80. Novo Nordisk Major Business
    Table 81. Novo Nordisk Recombinant Insulin Lispro Injection Product and Services
    Table 82. Novo Nordisk Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Novo Nordisk Recent Developments/Updates
    Table 84. Novo Nordisk Competitive Strengths & Weaknesses
    Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 86. Pfizer Major Business
    Table 87. Pfizer Recombinant Insulin Lispro Injection Product and Services
    Table 88. Pfizer Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Pfizer Competitive Strengths & Weaknesses
    Table 91. BI Basic Information, Manufacturing Base and Competitors
    Table 92. BI Major Business
    Table 93. BI Recombinant Insulin Lispro Injection Product and Services
    Table 94. BI Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. BI Recent Developments/Updates
    Table 96. BI Competitive Strengths & Weaknesses
    Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 98. Sanofi Major Business
    Table 99. Sanofi Recombinant Insulin Lispro Injection Product and Services
    Table 100. Sanofi Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Sanofi Recent Developments/Updates
    Table 102. Sanofi Competitive Strengths & Weaknesses
    Table 103. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
    Table 104. Takeda Pharmaceutical Company Major Business
    Table 105. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product and Services
    Table 106. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Takeda Pharmaceutical Company Recent Developments/Updates
    Table 108. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
    Table 109. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 110. Wanbang Biopharmaceuticals Major Business
    Table 111. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product and Services
    Table 112. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Wanbang Biopharmaceuticals Recent Developments/Updates
    Table 114. United Laboratories Basic Information, Manufacturing Base and Competitors
    Table 115. United Laboratories Major Business
    Table 116. United Laboratories Recombinant Insulin Lispro Injection Product and Services
    Table 117. United Laboratories Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Recombinant Insulin Lispro Injection Upstream (Raw Materials)
    Table 119. Recombinant Insulin Lispro Injection Typical Customers
    Table 120. Recombinant Insulin Lispro Injection Typical Distributors
List of Figure
    Figure 1. Recombinant Insulin Lispro Injection Picture
    Figure 2. World Recombinant Insulin Lispro Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Insulin Lispro Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Insulin Lispro Injection Production (2018-2029) & (K Units)
    Figure 5. World Recombinant Insulin Lispro Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Insulin Lispro Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Insulin Lispro Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Recombinant Insulin Lispro Injection Production (2018-2029) & (K Units)
    Figure 10. China Recombinant Insulin Lispro Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Recombinant Insulin Lispro Injection Production (2018-2029) & (K Units)
    Figure 12. Recombinant Insulin Lispro Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Recombinant Insulin Lispro Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Recombinant Insulin Lispro Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Recombinant Insulin Lispro Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Insulin Lispro Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Insulin Lispro Injection Markets in 2022
    Figure 26. United States VS China: Recombinant Insulin Lispro Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Insulin Lispro Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Insulin Lispro Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2022
    Figure 32. World Recombinant Insulin Lispro Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Insulin Lispro Injection Production Value Market Share by Type in 2022
    Figure 34. 1ML
    Figure 35. 3ML
    Figure 36. 10ML
    Figure 37. World Recombinant Insulin Lispro Injection Production Market Share by Type (2018-2029)
    Figure 38. World Recombinant Insulin Lispro Injection Production Value Market Share by Type (2018-2029)
    Figure 39. World Recombinant Insulin Lispro Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Recombinant Insulin Lispro Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Recombinant Insulin Lispro Injection Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Pharmacy
    Figure 44. World Recombinant Insulin Lispro Injection Production Market Share by Application (2018-2029)
    Figure 45. World Recombinant Insulin Lispro Injection Production Value Market Share by Application (2018-2029)
    Figure 46. World Recombinant Insulin Lispro Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Recombinant Insulin Lispro Injection Industry Chain
    Figure 48. Recombinant Insulin Lispro Injection Procurement Model
    Figure 49. Recombinant Insulin Lispro Injection Sales Model
    Figure 50. Recombinant Insulin Lispro Injection Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Recombinant Insulin Lispro Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Insulin Lispro Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 13 Jan 2023

date Medical Devices & Consumables

The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis

Global Recombinant Insulin Lispro Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Insulin Lispro Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Recombinant Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2024-2030

Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Medical Devices & Consumables

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Recombinant Insulin Lispro Injection

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>